Hematology/Oncology

Top Story

16 cancer care facilities receive achievement awards

November 19, 2017

The American College of Surgeons’ Commission on Cancer presented Outstanding Achievement Awards to 16 accredited cancer programs.

The awards are intended to recognize cancer programs that achieve excellence in providing quality care; motivate other cancer programs to work toward improving their level of care; facilitate dialogue between award recipients and health care professionals at other facilities, with the goal of sharing best practices; and encourage recipients to serve as quality-care resources to other cancer programs.

Yale School of Medicine appoints chair of surgery department

November 18, 2017
Nita Ahuja, MD, has been named chair of the department of surgery at Yale School of Medicine. Ahuja also will serve as chief of surgery at Yale New Haven Hospital.
In the Journals Plus

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype

November 17, 2017
Radiotherapy prolonged OS among patients with all stages of nodular lymphocytic Hodgkin lymphoma, including those with B-symptoms, according to study results. However…
Meeting News

High compliance with Optune linked to greatest survival benefit for glioblastoma

November 17, 2017
Patients with newly diagnosed glioblastoma who used the Optune device more than 90% of the time had the greatest chance for survival, according to a company-issued press…

ASCO expands enrollment for TAPUR study

November 17, 2017
ASCO announced four cohorts of Targeted Agent and Profiling Utilization Registry, or TAPUR, will enroll additional patients with a variety of cancers. The combination of…
More Headlines »
CME

Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

In 2016, the first immune checkpoint inhibitor was approved by the US Food and Drug Administration (FDA) for the…
More »
Video
Meeting News

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017
More »
Resource Centers

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today